In Memoriam: Professor James Tsai-An Hsu

Professor emeritus James Tsai-An Hsu of bioengineering and of chemical and biomolecular engineering, passed away on December 1, 2024. He was 77 years old.

Prof. Hsu was a distinguished chemical engineer and educator, renowned for his contributions to biopharmaceutical engineering. Born in Guangdong, China, he pursued his undergraduate studies at National Cheng Kung University in Taiwan. He furthered his education in the United States, earning a Master of Science from the University of Rhode Island in 1972 and a PhD from Northwestern University in 1979.

Diagnostics World spotlights Prof. Xuanhong Cheng’s work to advance understanding of CFS, long COVID

A recent feature published by Diagnostics World highlights Rossin College Professor Xuanhong Cheng (bioengineering/materials science and engineeing) and her research into the molecular and cellular properties of muscle tissue. This fundamental work, which uses advanced electrical sensors to study muscle stem cells, is part of an international effort to uncover biological insights that could inform future diagnostic advancements for chronic fatigue syndrome (CFS) and long COVID.

Rossin College faculty honored with university awards

Congratulations to the Rossin College faculty members who have been recognized with Lehigh University awards for their outstanding contributions to the Lehigh community during the 2024-2025 academic year.

  • Lehigh Early Career Award for Distinguished Teaching: Whitney Blocher McTigue, assistant professor, chemical and biomolecular engineering

This award is given to a member of the teaching staff for distinguished teaching performed during the academic year.

Smarter shipboard power

Traditionally, the scheduling and control of large-scale systems, such as power grids, microgrids, and naval shipboard power systems, have been managed independently. Enhanced coordination between these processes has the potential to significantly improve both energy efficiency and dynamic system performance.

Integrating CRISPR and biomaterials engineering: Paving the way for safer gene therapies

CRISPR is a powerful gene-editing tool that holds enormous potential for treating genetic diseases by allowing scientists to cut, replace, or delete mutations in DNA. It can also modify gene expression, temporarily amplifying or diminishing its effects. 

Yet, despite its promise, applying CRISPR (which is a reagent, or a substance that facilitates a reaction) in patients presents significant challenges.

Pages